Numerous studies have shown that oxidative stress resulting from an imbalance between
the production of free radicals and their neutralization by antioxidant enzymes is one of the …

To explore the mechanism of the Astragalus membranaceous (AM)-Angelica sinensis (AS)
compound in the treatment of diabetic nephropathy (DN) we used network pharmacology …

The antidiabetic drug canagliflozin is reported to possess several cardioprotective effects.
However, no studies have investigated protective effects of canagliflozin in isoprenaline …

Diabetes is a leading cause of chronic kidney disease, and the high prevalence of
sympathetic nervous system (SNS) hyperactivity in diabetic patients makes them further …

The present study was carried out to explore a novel strategy with the hypothesis that the
combined treatment with standard antidiabetic drug metformin (MET) and chitosan stabilized …

Background: this study examined the metformin (MF) and/or chitosan stabilized selenium
nanoparticles (CH-SeNPs) efficacy to alleviate the male reproductive function impairment in …

Alzheimer's disease (AD) is a progressive neurological illness characterized by memory loss
and cognitive deterioration. Dapagliflozin was suggested to attenuate the memory …

The metabolic syndrome (MetS) refers to the co‐occurrence of risk factors, including
hyperglycaemia, increased body weight, hypertension and dyslipidemia, which eventually …

Sodium-glucose transport protein 2 (SGLT-2) inhibitors are approved antidiabetic drugs with
a beneficial effect on reducing major adverse cardiac events and heart failure …

Liver inflammation and necrosis are the foremost problems interlinked with diabetes mellitus
(DM). The methanolic extract of Sargassum muticum (MESM) plays a hepatoprotective role …